BOCH
CABA icon

Blue Owl Capital Holdings’s Cabaletta Bio CABA Stock Holding History

Blue Owl Capital Holdings’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Buy
+714,710
New +$2.35M 0.33% 32
2025
Q3 		– Sell
-1,125,000
Closed -$1.71M – 75
2025
Q2 		$1.71M Buy
+1,125,000
New +$1.75M 0.55% 33

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Blue Owl Capital Holdings's CABA Position: Q2 2026 in Review

Blue Owl Capital Holdings opened a new position in Cabaletta Bio (CABA) in Q2 2026: 714,710 shares worth $2.22M. The stake represents 0.33% of the portfolio and ranks #32 among its holdings. This is a return to the name: Blue Owl Capital Holdings previously reported a position in CABA as recently as Q2 2025.

Blue Owl Capital Holdings first reported a position in CABA in Q2 2025 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Blue Owl Capital Holdings held 714,710 shares of Cabaletta Bio worth $2.22M as of Q2 2026.
  • Cabaletta Bio was a new Blue Owl Capital Holdings position in Q2 2026.
  • Cabaletta Bio made up 0.33% of Blue Owl Capital Holdings's portfolio in Q2 2026, its #32 holding.
  • Blue Owl Capital Holdings first reported a position in Cabaletta Bio in Q2 2025 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.